PDB Short entry for 2QON HEADER TRANSFERASE 20-JUL-07 2QON TITLE HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE TITLE 2 MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: JUXTAMEMBRANE SEGMENT AND KINASE DOMAIN: RESIDUES 577-947; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: PLACENTA; SOURCE 6 GENE: EPHA3; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28A-LIC KEYWDS RECEPTOR TYROSINE KINASE, JUXTAMEMBRANE SEGMENT, STRUCTURAL GENOMICS, KEYWDS 2 MUTANT, STRUCTURAL GENOMICS CONSORTIUM, SGC, ATP-BINDING, KEYWDS 3 NUCLEOTIDE-BINDING, PHOSPHORYLATION, TRANSFERASE, TRANSMEMBRANE, KEYWDS 4 TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR T.DAVIS,J.R.WALKER,E.M.NEWMAN,F.MACKENZIE,C.BUTLER-COLE,J.WEIGELT, AUTHOR 2 M.SUNDSTROM,C.H.ARROWSMITH,A.M.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON, AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 8 15-NOV-23 2QON 1 REMARK REVDAT 7 30-AUG-23 2QON 1 REMARK REVDAT 6 20-OCT-21 2QON 1 REMARK SEQADV LINK REVDAT 5 25-OCT-17 2QON 1 REMARK REVDAT 4 13-JUL-11 2QON 1 VERSN REVDAT 3 24-FEB-09 2QON 1 VERSN REVDAT 2 01-JUL-08 2QON 1 JRNL REVDAT 1 28-AUG-07 2QON 0 JRNL AUTH T.L.DAVIS,J.R.WALKER,P.LOPPNAU,C.BUTLER-COLE, JRNL AUTH 2 A.ALLALI-HASSANI,S.DHE-PAGANON JRNL TITL AUTOREGULATION BY THE JUXTAMEMBRANE REGION OF THE HUMAN JRNL TITL 2 EPHRIN RECEPTOR TYROSINE KINASE A3 (EPHA3). JRNL REF STRUCTURE V. 16 873 2008 JRNL REFN ISSN 0969-2126 JRNL PMID 18547520 JRNL DOI 10.1016/J.STR.2008.03.008 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 26888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.191 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1346 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1103 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 54.07 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2233 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.115 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.486 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2361 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1657 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3203 ; 1.526 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4052 ; 0.944 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 304 ; 6.273 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 101 ;34.304 ;23.663 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 437 ;12.848 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;17.443 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 357 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2603 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 474 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 528 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1830 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1193 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1191 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 230 ; 0.181 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.232 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 61 ; 0.255 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 34 ; 0.176 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1899 ; 1.299 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 585 ; 0.230 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2362 ; 1.467 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1064 ; 2.230 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 832 ; 3.207 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2QON COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000043861. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26894 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 57.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.44800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2GSF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MG/ML PROTEIN, 25% PEG 3350, 0.2M REMARK 280 AMMONIUM SULFATE, 0.1M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.31050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 575 REMARK 465 SER A 576 REMARK 465 ASP A 577 REMARK 465 GLU A 578 REMARK 465 LYS A 579 REMARK 465 ARG A 580 REMARK 465 LEU A 581 REMARK 465 HIS A 582 REMARK 465 PHE A 583 REMARK 465 GLY A 584 REMARK 465 ASN A 585 REMARK 465 GLY A 586 REMARK 465 HIS A 587 REMARK 465 LEU A 588 REMARK 465 LYS A 589 REMARK 465 LEU A 590 REMARK 465 PRO A 591 REMARK 465 GLY A 592 REMARK 465 LEU A 593 REMARK 465 ARG A 594 REMARK 465 ASP A 598 REMARK 465 PRO A 599 REMARK 465 HIS A 600 REMARK 465 THR A 601 REMARK 465 PHE A 602 REMARK 465 GLU A 603 REMARK 465 ASP A 604 REMARK 465 PRO A 605 REMARK 465 THR A 606 REMARK 465 GLN A 607 REMARK 465 VAL A 770 REMARK 465 LEU A 771 REMARK 465 GLU A 772 REMARK 465 ASP A 773 REMARK 465 ASP A 774 REMARK 465 PRO A 775 REMARK 465 GLU A 776 REMARK 465 ALA A 777 REMARK 465 ALA A 778 REMARK 465 TYR A 779 REMARK 465 THR A 780 REMARK 465 THR A 781 REMARK 465 ARG A 782 REMARK 465 GLY A 783 REMARK 465 GLY A 784 REMARK 465 LYS A 785 REMARK 465 ALA A 895 REMARK 465 ALA A 896 REMARK 465 ARG A 897 REMARK 465 SER A 906 REMARK 465 ASN A 907 REMARK 465 VAL A 908 REMARK 465 ASP A 909 REMARK 465 ILE A 910 REMARK 465 THR A 911 REMARK 465 THR A 912 REMARK 465 PHE A 913 REMARK 465 ARG A 914 REMARK 465 THR A 915 REMARK 465 THR A 916 REMARK 465 GLY A 917 REMARK 465 ASP A 918 REMARK 465 TRP A 919 REMARK 465 LEU A 920 REMARK 465 ASN A 921 REMARK 465 GLY A 922 REMARK 465 VAL A 923 REMARK 465 TRP A 924 REMARK 465 THR A 925 REMARK 465 ALA A 926 REMARK 465 HIS A 927 REMARK 465 CYS A 928 REMARK 465 LYS A 929 REMARK 465 GLU A 930 REMARK 465 ILE A 931 REMARK 465 PHE A 932 REMARK 465 THR A 933 REMARK 465 GLY A 934 REMARK 465 VAL A 935 REMARK 465 GLU A 936 REMARK 465 TYR A 937 REMARK 465 SER A 938 REMARK 465 SER A 939 REMARK 465 CYS A 940 REMARK 465 ASP A 941 REMARK 465 THR A 942 REMARK 465 ILE A 943 REMARK 465 ALA A 944 REMARK 465 LYS A 945 REMARK 465 ILE A 946 REMARK 465 SER A 947 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG2 THR A 608 O HOH A 310 0.82 REMARK 500 O HOH A 44 O HOH A 163 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 645 -2.37 78.66 REMARK 500 ARG A 745 -10.11 71.70 REMARK 500 ARG A 745 -13.70 74.75 REMARK 500 ASP A 764 74.52 60.62 REMARK 500 PRO A 787 89.51 -66.11 REMARK 500 TYR A 798 32.13 -149.02 REMARK 500 TRP A 826 -128.92 45.71 REMARK 500 TRP A 826 -128.41 45.71 REMARK 500 ASP A 904 -115.16 54.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 609 HIS A 610 149.51 REMARK 500 ASP A 904 GLN A 905 147.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 991 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GSF RELATED DB: PDB REMARK 900 THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION REMARK 900 RELATED ID: 2QO2 RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO REMARK 900 STRUCTURE REMARK 900 RELATED ID: 2QO7 RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP- REMARK 900 PNP BOUND REMARK 900 RELATED ID: 2QO9 RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP- REMARK 900 PNP BOUND REMARK 900 RELATED ID: 2QOB RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE REMARK 900 RELATED ID: 2QOC RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE REMARK 900 RELATED ID: 2QOD RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT REMARK 900 RELATED ID: 2QOF RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT REMARK 900 RELATED ID: 2QOI RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE REMARK 900 MUTANT REMARK 900 RELATED ID: 2QOK RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A REMARK 900 TRIPLE MUTANT REMARK 900 RELATED ID: 2QOL RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE REMARK 900 MUTANT REMARK 900 RELATED ID: 2QOO RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F REMARK 900 TRIPLE MUTANT REMARK 900 RELATED ID: 2QOQ RELATED DB: PDB REMARK 900 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND REMARK 900 STRUCTURE DBREF 2QON A 577 947 UNP Q6P4R6 Q6P4R6_HUMAN 577 947 SEQADV 2QON GLY A 575 UNP Q6P4R6 EXPRESSION TAG SEQADV 2QON SER A 576 UNP Q6P4R6 EXPRESSION TAG SEQADV 2QON PHE A 596 UNP Q6P4R6 TYR 596 ENGINEERED MUTATION SEQADV 2QON PHE A 602 UNP Q6P4R6 TYR 602 ENGINEERED MUTATION SEQADV 2QON ALA A 742 UNP Q6P4R6 TYR 742 ENGINEERED MUTATION SEQRES 1 A 373 GLY SER ASP GLU LYS ARG LEU HIS PHE GLY ASN GLY HIS SEQRES 2 A 373 LEU LYS LEU PRO GLY LEU ARG THR PHE VAL ASP PRO HIS SEQRES 3 A 373 THR PHE GLU ASP PRO THR GLN THR VAL HIS GLU PHE ALA SEQRES 4 A 373 LYS GLU LEU ASP ALA THR ASN ILE SER ILE ASP LYS VAL SEQRES 5 A 373 VAL GLY ALA GLY GLU PHE GLY GLU VAL CYS SER GLY ARG SEQRES 6 A 373 LEU LYS LEU PRO SER LYS LYS GLU ILE SER VAL ALA ILE SEQRES 7 A 373 LYS THR LEU LYS VAL GLY TYR THR GLU LYS GLN ARG ARG SEQRES 8 A 373 ASP PHE LEU GLY GLU ALA SER ILE MET GLY GLN PHE ASP SEQRES 9 A 373 HIS PRO ASN ILE ILE ARG LEU GLU GLY VAL VAL THR LYS SEQRES 10 A 373 SER LYS PRO VAL MET ILE VAL THR GLU PTR MET GLU ASN SEQRES 11 A 373 GLY SER LEU ASP SER PHE LEU ARG LYS HIS ASP ALA GLN SEQRES 12 A 373 PHE THR VAL ILE GLN LEU VAL GLY MET LEU ARG GLY ILE SEQRES 13 A 373 ALA SER GLY MET LYS TYR LEU SER ASP MET GLY ALA VAL SEQRES 14 A 373 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU ILE ASN SER SEQRES 15 A 373 ASN LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 16 A 373 VAL LEU GLU ASP ASP PRO GLU ALA ALA TYR THR THR ARG SEQRES 17 A 373 GLY GLY LYS ILE PRO ILE ARG TRP THR SER PRO GLU ALA SEQRES 18 A 373 ILE ALA TYR ARG LYS PHE THR SER ALA SER ASP VAL TRP SEQRES 19 A 373 SER TYR GLY ILE VAL LEU TRP GLU VAL MET SER TYR GLY SEQRES 20 A 373 GLU ARG PRO TYR TRP GLU MET SER ASN GLN ASP VAL ILE SEQRES 21 A 373 LYS ALA VAL ASP GLU GLY TYR ARG LEU PRO PRO PRO MET SEQRES 22 A 373 ASP CYS PRO ALA ALA LEU TYR GLN LEU MET LEU ASP CYS SEQRES 23 A 373 TRP GLN LYS ASP ARG ASN ASN ARG PRO LYS PHE GLU GLN SEQRES 24 A 373 ILE VAL SER ILE LEU ASP LYS LEU ILE ARG ASN PRO GLY SEQRES 25 A 373 SER LEU LYS ILE ILE THR SER ALA ALA ALA ARG PRO SER SEQRES 26 A 373 ASN LEU LEU LEU ASP GLN SER ASN VAL ASP ILE THR THR SEQRES 27 A 373 PHE ARG THR THR GLY ASP TRP LEU ASN GLY VAL TRP THR SEQRES 28 A 373 ALA HIS CYS LYS GLU ILE PHE THR GLY VAL GLU TYR SER SEQRES 29 A 373 SER CYS ASP THR ILE ALA LYS ILE SER MODRES 2QON PTR A 701 TYR O-PHOSPHOTYROSINE HET PTR A 701 16 HET GOL A 991 6 HETNAM PTR O-PHOSPHOTYROSINE HETNAM GOL GLYCEROL HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 GOL C3 H8 O3 FORMUL 3 HOH *333(H2 O) HELIX 1 1 ASP A 617 THR A 619 5 3 HELIX 2 2 THR A 660 GLY A 675 1 16 HELIX 3 3 SER A 706 LYS A 713 1 8 HELIX 4 4 THR A 719 MET A 740 1 22 HELIX 5 5 ALA A 748 ARG A 750 5 3 HELIX 6 6 PRO A 787 THR A 791 5 5 HELIX 7 7 SER A 792 ARG A 799 1 8 HELIX 8 8 THR A 802 SER A 819 1 18 HELIX 9 9 SER A 829 GLU A 839 1 11 HELIX 10 10 PRO A 850 TRP A 861 1 12 HELIX 11 11 ASP A 864 ARG A 868 5 5 HELIX 12 12 LYS A 870 ASN A 884 1 15 HELIX 13 13 PRO A 885 ILE A 890 5 6 SHEET 1 A 5 ILE A 621 ALA A 629 0 SHEET 2 A 5 GLU A 634 LYS A 641 -1 O VAL A 635 N GLY A 628 SHEET 3 A 5 GLU A 647 THR A 654 -1 O ILE A 652 N CYS A 636 SHEET 4 A 5 MET A 696 GLU A 700 -1 O THR A 699 N ALA A 651 SHEET 5 A 5 LEU A 685 VAL A 689 -1 N GLY A 687 O VAL A 698 SHEET 1 B 2 ILE A 752 ILE A 754 0 SHEET 2 B 2 CYS A 760 VAL A 762 -1 O LYS A 761 N LEU A 753 SHEET 1 C 2 TYR A 841 ARG A 842 0 SHEET 2 C 2 LEU A 902 LEU A 903 -1 O LEU A 902 N ARG A 842 LINK C GLU A 700 N PTR A 701 1555 1555 1.33 LINK C PTR A 701 N MET A 702 1555 1555 1.33 CISPEP 1 LYS A 693 PRO A 694 0 3.68 SITE 1 AC1 4 HOH A 24 GLY A 675 PHE A 677 LEU A 685 CRYST1 54.154 38.621 76.345 90.00 102.66 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018466 0.000000 0.004148 0.00000 SCALE2 0.000000 0.025893 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013425 0.00000